Phase I trial immunological adjuvant QS-21 with a GM2 ganglioside-KLH conjugate vaccine in patients with malignant melanoma Meeting Abstract

  

Authors:	Helling, F.; Livingston, P. O.; Adluri, S.; Shang, A.; Yao, T. J.; Kensil, C. R.; Newman, M. J.; Marciani, D.
Abstract Title:	Phase I trial immunological adjuvant QS-21 with a GM2 ganglioside-KLH conjugate vaccine in patients with malignant melanoma
Meeting Title:	85th Annual Meeting of the American Association for Cancer Research (AACR)
Keywords:	therapy; cancer immunology; meeting abstract
Journal Title:	Proceedings of the American Association for Cancer Research Annual Meeting
Volume:	35
Meeting Dates:	1994 Apr 10-13
Meeting Location:	San Francisco, CA
ISSN:	0197-016X
Publisher:	American Association for Cancer Research
Date Published:	1994-03-01
Start Page:	515
Language:	English
ACCESSION:	BCI:BCI199497303846
PROVIDER:	biosis
Notes:	Meeting Abstract: 3068 -- Source: Biosis

https://synapse.mskcc.org/synapse/works/has_related_data_chk/143603